Royal Children’s Hospital investigates toxic chemotherapy drug exposure risks from unapproved gloves

Consensus Summary

Staff at Melbourne’s Royal Children’s Hospital (RCH) may have been exposed to toxic chemotherapy drugs for up to 10 years due to the use of sterile gloves not rated for handling cytotoxic agents. The hospital has since replaced these gloves with ones meeting the updated international standard, following an escalation in late August. WorkSafe Victoria was notified on August 26, prompting the review. The issue arose despite some areas of the hospital adopting the new standard about a decade ago, while others continued using the older, less protective gloves, including in the Kookaburra Cancer Care ward for patients with latex allergies.

The problem stems from a gap between global safety standards and local practices. The international standard for chemotherapy gloves was updated about a decade ago, but inconsistencies within the hospital meant some staff remained unprotected. The hospital’s spokesperson confirmed that the gloves were removed and replaced after the issue was raised, though discrepancies in implementation across different wards have raised concerns about how the problem was managed over time. WorkSafe Victoria’s involvement underscores the seriousness of the potential exposure risks, which could lead to health issues such as fertility changes, liver damage, or genetic mutations for staff.

Key figures involved include RCH’s chief executive Peter Steer and executive director of nursing services Kath Riddell, who apologized to staff in an email. The hospital has hired an independent organization to assess the gloves’ safety and investigate exposure risks. Meanwhile, the nursing union has criticized the inconsistent standards across hospitals, calling for a broader safety alert. ABC reports a hospital worker expressed devastation over the potential exposure, highlighting the emotional toll of the situation. The union’s Maddy Harradence has pushed for thorough contact tracing of all affected staff and consistent clinical governance moving forward.

While both 7NEWS and ABC agree on the core timeline—including the August 26 notification and the decade-long use of unapproved gloves—they differ slightly in emphasis. ABC highlights the union’s call for systemic change and the emotional impact on workers, while 7NEWS focuses more on WorkSafe Victoria’s ongoing role and the hospital’s commitment to transparency. Neither source contradicts the other on key facts, but ABC provides more detail on the union’s stance and potential broader implications for other hospitals, whereas 7NEWS emphasizes the hospital’s immediate response and testing efforts.

The investigation is ongoing, with the hospital promising to share further information with staff as it becomes available. HealthShare Victoria is also examining whether other hospitals in the state may have used the same unapproved gloves. The unresolved question remains whether any staff were exposed to harmful levels of chemotherapy toxins, and if so, what long-term health consequences they may face. The hospital’s transparency and the regulator’s involvement suggest a commitment to addressing the issue, but the full extent of the problem may not be clear until the independent testing is completed.